APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Companion Animal Ear Infection

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Companion Animal Ear Infection Market Outlook and Growth Opportunities 2026

30 December 2025196 pages

Choose your research edition.

Industry ResearchCompanion Animal Ear Infection Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Companion Animal Ear Infection Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Companion Animal Ear Infection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Companion Animal Ear Infection Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Companion Animal Ear Infection Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Companion Animal Ear Infection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Companion Animal Ear Infection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Companion Animal Ear Infection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Companion Animal Ear Infection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Companion Animal Ear Infection market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Companion Animal Ear Infection market include Calder Vets, Dechra Pharmaceuticals, Elanco Animal Health Incorporated, Penn Veterinary Supply, Piedmont Animal Health, VCA, Vedco, Vetoquinol S.A. and Virbac S.A., among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Companion Animal Ear Infection market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Companion Animal Ear Infection and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Companion Animal Ear Infection revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Companion Animal Ear Infection market.

Companion Animal Ear Infection Segment by Company

Calder Vets

Dechra Pharmaceuticals

Elanco Animal Health Incorporated

Penn Veterinary Supply

Piedmont Animal Health

VCA

Vedco

Vetoquinol S.A.

Virbac S.A.

Wedgewood Village Pharmacy

Merck & Co

Companion Animal Ear Infection Segment by Type

Otitis Externa

Otitis Interna

Companion Animal Ear Infection Segment by Application

Pet Hospital

Treatment Center

Others

Companion Animal Ear Infection Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Companion Animal Ear Infection status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Companion Animal Ear Infection key companies, revenue, market share, and recent developments.

3. To split the Companion Animal Ear Infection breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Companion Animal Ear Infection market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Companion Animal Ear Infection significant trends, drivers, influence factors in global and regions.

6. To analyze Companion Animal Ear Infection competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Companion Animal Ear Infection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Companion Animal Ear Infection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Companion Animal Ear Infection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Companion Animal Ear Infection industry.

Chapter 3: Detailed analysis of Companion Animal Ear Infection company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Companion Animal Ear Infection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Companion Animal Ear Infection in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Companion Animal Ear Infection Industry Trends Table 2. Companion Animal Ear Infection Industry Drivers Table 3. Companion Animal Ear Infection Industry Opportunities and Challenges Table 4. Companion Animal Ear Infection Industry Restraints Table 5. Global Companion Animal Ear Infection Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Companion Animal Ear Infection Revenue Share by Company (2021-2026) Table 7. Global Companion Animal Ear Infection Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Companion Animal Ear Infection Key Company Manufacturing Base & Headquarters Table 9. Global Companion Animal Ear Infection Company, Product Type & Application Table 10. Global Companion Animal Ear Infection Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Companion Animal Ear Infection by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Otitis Externa Table 15. Significant Companies of Otitis Interna Table 16. Global Companion Animal Ear Infection Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Companion Animal Ear Infection Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Companion Animal Ear Infection Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Companion Animal Ear Infection Sales Value Share by Type (2021-2026) Table 20. Global Companion Animal Ear Infection Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Pet Hospital Table 22. Significant Companies of Treatment Center Table 23. Significant Companies of Others Table 24. Global Companion Animal Ear Infection Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Companion Animal Ear Infection Sales Value by Application (2021-2026) & (US$ Million) Table 26. Global Companion Animal Ear Infection Sales Value by Application (2027-2032) & (US$ Million) Table 27. Global Companion Animal Ear Infection Sales Value Share by Application (2021-2026) Table 28. Global Companion Animal Ear Infection Sales Value Share by Application (2027-2032) Table 29. Global Companion Animal Ear Infection Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Companion Animal Ear Infection Sales Value by Region (2021-2026) & (US$ Million) Table 31. Global Companion Animal Ear Infection Sales Value Share by Region (2021-2026) Table 32. Global Companion Animal Ear Infection Sales Value by Region (2027-2032) & (US$ Million) Table 33. Global Companion Animal Ear Infection Sales Value Share by Region (2027-2032) Table 34. Global Companion Animal Ear Infection Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Companion Animal Ear Infection Sales Value by Country (2021-2026) & (US$ Million) Table 36. Global Companion Animal Ear Infection Sales Value Market Share by Country (2021-2026) Table 37. Global Companion Animal Ear Infection Sales Value by Country (2027-2032) & (US$ Million) Table 38. Global Companion Animal Ear Infection Sales Value Market Share by Country (2027-2032) Table 39. Calder Vets Company Information Table 40. Calder Vets Business Overview Table 41. Calder Vets Companion Animal Ear Infection Revenue (US$ Million) and Gross Margin (2021-2026) Table 42. Calder Vets Companion Animal Ear Infection Product Portfolio Table 43. Calder Vets Recent Development Table 44. Dechra Pharmaceuticals Company Information Table 45. Dechra Pharmaceuticals Business Overview Table 46. Dechra Pharmaceuticals Companion Animal Ear Infection Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. Dechra Pharmaceuticals Companion Animal Ear Infection Product Portfolio Table 48. Dechra Pharmaceuticals Recent Development Table 49. Elanco Animal Health Incorporated Company Information Table 50. Elanco Animal Health Incorporated Business Overview Table 51. Elanco Animal Health Incorporated Companion Animal Ear Infection Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. Elanco Animal Health Incorporated Companion Animal Ear Infection Product Portfolio Table 53. Elanco Animal Health Incorporated Recent Development Table 54. Penn Veterinary Supply Company Information Table 55. Penn Veterinary Supply Business Overview Table 56. Penn Veterinary Supply Companion Animal Ear Infection Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. Penn Veterinary Supply Companion Animal Ear Infection Product Portfolio Table 58. Penn Veterinary Supply Recent Development Table 59. Piedmont Animal Health Company Information Table 60. Piedmont Animal Health Business Overview Table 61. Piedmont Animal Health Companion Animal Ear Infection Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. Piedmont Animal Health Companion Animal Ear Infection Product Portfolio Table 63. Piedmont Animal Health Recent Development Table 64. VCA Company Information Table 65. VCA Business Overview Table 66. VCA Companion Animal Ear Infection Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. VCA Companion Animal Ear Infection Product Portfolio Table 68. VCA Recent Development Table 69. Vedco Company Information Table 70. Vedco Business Overview Table 71. Vedco Companion Animal Ear Infection Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Vedco Companion Animal Ear Infection Product Portfolio Table 73. Vedco Recent Development Table 74. Vetoquinol S.A. Company Information Table 75. Vetoquinol S.A. Business Overview Table 76. Vetoquinol S.A. Companion Animal Ear Infection Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Vetoquinol S.A. Companion Animal Ear Infection Product Portfolio Table 78. Vetoquinol S.A. Recent Development Table 79. Virbac S.A. Company Information Table 80. Virbac S.A. Business Overview Table 81. Virbac S.A. Companion Animal Ear Infection Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Virbac S.A. Companion Animal Ear Infection Product Portfolio Table 83. Virbac S.A. Recent Development Table 84. Wedgewood Village Pharmacy Company Information Table 85. Wedgewood Village Pharmacy Business Overview Table 86. Wedgewood Village Pharmacy Companion Animal Ear Infection Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Wedgewood Village Pharmacy Companion Animal Ear Infection Product Portfolio Table 88. Wedgewood Village Pharmacy Recent Development Table 89. Merck & Co Company Information Table 90. Merck & Co Business Overview Table 91. Merck & Co Companion Animal Ear Infection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Merck & Co Companion Animal Ear Infection Product Portfolio Table 93. Merck & Co Recent Development Table 94. Research Programs/Design for This Report Table 95. Authors List of This Report Table 96. Secondary Sources Table 97. Primary Sources List of Figures Figure 1. Companion Animal Ear Infection Product Image Figure 2. Global Companion Animal Ear Infection Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Companion Animal Ear Infection Market Size (2021-2032) & (US$ Million) Figure 4. Global Companion Animal Ear Infection Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Otitis Externa Image Figure 8. Otitis Interna Image Figure 9. Global Companion Animal Ear Infection Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Companion Animal Ear Infection Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Companion Animal Ear Infection Sales Value Share by Type (2021-2032) Figure 12. Pet Hospital Image Figure 13. Treatment Center Image Figure 14. Others Image Figure 15. Global Companion Animal Ear Infection Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Companion Animal Ear Infection Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Companion Animal Ear Infection Sales Value Share by Application (2021-2032) Figure 18. Global Companion Animal Ear Infection Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Companion Animal Ear Infection Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 20. North America Companion Animal Ear Infection Sales Value (2021-2032) & (US$ Million) Figure 21. North America Companion Animal Ear Infection Sales Value Share by Country (%), 2025 VS 2032 Figure 22. Europe Companion Animal Ear Infection Sales Value (2021-2032) & (US$ Million) Figure 23. Europe Companion Animal Ear Infection Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Asia-Pacific Companion Animal Ear Infection Sales Value (2021-2032) & (US$ Million) Figure 25. Asia-Pacific Companion Animal Ear Infection Sales Value Share by Country (%), 2025 VS 2032 Figure 26. South America Companion Animal Ear Infection Sales Value (2021-2032) & (US$ Million) Figure 27. South America Companion Animal Ear Infection Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Middle East & Africa Companion Animal Ear Infection Sales Value (2021-2032) & (US$ Million) Figure 29. Middle East & Africa Companion Animal Ear Infection Sales Value Share by Country (%), 2025 VS 2032 Figure 30. USA Companion Animal Ear Infection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 31. USA Companion Animal Ear Infection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 32. USA Companion Animal Ear Infection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 33. Canada Companion Animal Ear Infection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. Canada Companion Animal Ear Infection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. Canada Companion Animal Ear Infection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Mexico Companion Animal Ear Infection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Mexico Companion Animal Ear Infection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Mexico Companion Animal Ear Infection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Germany Companion Animal Ear Infection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Germany Companion Animal Ear Infection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Germany Companion Animal Ear Infection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. France Companion Animal Ear Infection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. France Companion Animal Ear Infection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. France Companion Animal Ear Infection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. U.K. Companion Animal Ear Infection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. U.K. Companion Animal Ear Infection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. U.K. Companion Animal Ear Infection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Italy Companion Animal Ear Infection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Italy Companion Animal Ear Infection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Italy Companion Animal Ear Infection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Spain Companion Animal Ear Infection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Spain Companion Animal Ear Infection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Spain Companion Animal Ear Infection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Russia Companion Animal Ear Infection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Russia Companion Animal Ear Infection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Russia Companion Animal Ear Infection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Netherlands Companion Animal Ear Infection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Netherlands Companion Animal Ear Infection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Netherlands Companion Animal Ear Infection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Nordic Countries Companion Animal Ear Infection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Nordic Countries Companion Animal Ear Infection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Nordic Countries Companion Animal Ear Infection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. China Companion Animal Ear Infection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. China Companion Animal Ear Infection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. China Companion Animal Ear Infection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Japan Companion Animal Ear Infection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Japan Companion Animal Ear Infection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Japan Companion Animal Ear Infection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. South Korea Companion Animal Ear Infection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. South Korea Companion Animal Ear Infection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. South Korea Companion Animal Ear Infection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. India Companion Animal Ear Infection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. India Companion Animal Ear Infection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. India Companion Animal Ear Infection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Australia Companion Animal Ear Infection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Australia Companion Animal Ear Infection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Australia Companion Animal Ear Infection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Southeast Asia Companion Animal Ear Infection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Southeast Asia Companion Animal Ear Infection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Southeast Asia Companion Animal Ear Infection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Brazil Companion Animal Ear Infection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Brazil Companion Animal Ear Infection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Brazil Companion Animal Ear Infection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Argentina Companion Animal Ear Infection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Argentina Companion Animal Ear Infection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Argentina Companion Animal Ear Infection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Chile Companion Animal Ear Infection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Chile Companion Animal Ear Infection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Chile Companion Animal Ear Infection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Colombia Companion Animal Ear Infection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Colombia Companion Animal Ear Infection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Colombia Companion Animal Ear Infection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Peru Companion Animal Ear Infection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Peru Companion Animal Ear Infection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Peru Companion Animal Ear Infection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Saudi Arabia Companion Animal Ear Infection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Saudi Arabia Companion Animal Ear Infection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Companion Animal Ear Infection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Israel Companion Animal Ear Infection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Israel Companion Animal Ear Infection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Israel Companion Animal Ear Infection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. UAE Companion Animal Ear Infection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. UAE Companion Animal Ear Infection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. UAE Companion Animal Ear Infection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Turkey Companion Animal Ear Infection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Turkey Companion Animal Ear Infection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Turkey Companion Animal Ear Infection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Iran Companion Animal Ear Infection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Iran Companion Animal Ear Infection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Iran Companion Animal Ear Infection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Egypt Companion Animal Ear Infection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Egypt Companion Animal Ear Infection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Egypt Companion Animal Ear Infection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Years Considered Figure 115. Research Process Figure 116. Key Executives Interviewed

Scope & coverage.

Types
  • Otitis Externa
  • Otitis Interna
Applications
  • Pet Hospital
  • Treatment Center
  • Others
Companies covered
  • Calder Vets
  • Dechra Pharmaceuticals
  • Elanco Animal Health Incorporated
  • Penn Veterinary Supply
  • Piedmont Animal Health
  • VCA
  • Vedco
  • Vetoquinol S.A.
  • Virbac S.A.
  • Wedgewood Village Pharmacy
  • Merck & Co

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Companion Animal Ear Infection Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Companion Animal Ear Infection Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Companion Animal Ear Infection Market Dynamics
  1. 2.1 Companion Animal Ear Infection Industry Trends
  2. 2.2 Companion Animal Ear Infection Industry Drivers
  3. 2.3 Companion Animal Ear Infection Industry Opportunities and Challenges
  4. 2.4 Companion Animal Ear Infection Industry Restraints
3 Companion Animal Ear Infection Market by Company
  1. 3.1 Global Companion Animal Ear Infection Company Revenue Ranking in 2025
  2. 3.2 Global Companion Animal Ear Infection Revenue by Company (2021-2026)
  3. 3.3 Global Companion Animal Ear Infection Company Ranking (2024-2026)
  4. 3.4 Global Companion Animal Ear Infection Company Manufacturing Base and Headquarters
  5. 3.5 Global Companion Animal Ear Infection Company Product Type and Application
  6. 3.6 Global Companion Animal Ear Infection Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Companion Animal Ear Infection Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Companion Animal Ear Infection Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Companion Animal Ear Infection Market by Type
  1. 4.1 Companion Animal Ear Infection Type Introduction
  2. 4.1.1 Otitis Externa
  3. 4.1.2 Otitis Interna
  4. 4.2 Global Companion Animal Ear Infection Sales Value by Type
  5. 4.2.1 Global Companion Animal Ear Infection Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Companion Animal Ear Infection Sales Value by Type (2021-2032)
  7. 4.2.3 Global Companion Animal Ear Infection Sales Value Share by Type (2021-2032)
5 Companion Animal Ear Infection Market by Application
  1. 5.1 Companion Animal Ear Infection Application Introduction
  2. 5.1.1 Pet Hospital
  3. 5.1.2 Treatment Center
  4. 5.1.3 Others
  5. 5.2 Global Companion Animal Ear Infection Sales Value by Application
  6. 5.2.1 Global Companion Animal Ear Infection Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Companion Animal Ear Infection Sales Value by Application (2021-2032)
  8. 5.2.3 Global Companion Animal Ear Infection Sales Value Share by Application (2021-2032)
6 Companion Animal Ear Infection Regional Value Analysis
  1. 6.1 Global Companion Animal Ear Infection Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Companion Animal Ear Infection Sales Value by Region (2021-2032)
  3. 6.2.1 Global Companion Animal Ear Infection Sales Value by Region: 2021-2026
  4. 6.2.2 Global Companion Animal Ear Infection Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Companion Animal Ear Infection Sales Value (2021-2032)
  7. 6.3.2 North America Companion Animal Ear Infection Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Companion Animal Ear Infection Sales Value (2021-2032)
  10. 6.4.2 Europe Companion Animal Ear Infection Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Companion Animal Ear Infection Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Companion Animal Ear Infection Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Companion Animal Ear Infection Sales Value (2021-2032)
  16. 6.6.2 South America Companion Animal Ear Infection Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Companion Animal Ear Infection Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Companion Animal Ear Infection Sales Value Share by Country, 2025 VS 2032
7 Companion Animal Ear Infection Country-level Value Analysis
  1. 7.1 Global Companion Animal Ear Infection Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Companion Animal Ear Infection Sales Value by Country (2021-2032)
  3. 7.2.1 Global Companion Animal Ear Infection Sales Value by Country (2021-2026)
  4. 7.2.2 Global Companion Animal Ear Infection Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Companion Animal Ear Infection Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Companion Animal Ear Infection Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Companion Animal Ear Infection Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Companion Animal Ear Infection Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Companion Animal Ear Infection Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Companion Animal Ear Infection Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Companion Animal Ear Infection Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Companion Animal Ear Infection Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Companion Animal Ear Infection Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Companion Animal Ear Infection Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Companion Animal Ear Infection Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Companion Animal Ear Infection Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Companion Animal Ear Infection Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Companion Animal Ear Infection Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Companion Animal Ear Infection Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Companion Animal Ear Infection Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Companion Animal Ear Infection Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Companion Animal Ear Infection Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Companion Animal Ear Infection Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Companion Animal Ear Infection Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Companion Animal Ear Infection Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Companion Animal Ear Infection Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Companion Animal Ear Infection Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Companion Animal Ear Infection Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Companion Animal Ear Infection Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Companion Animal Ear Infection Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Companion Animal Ear Infection Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Companion Animal Ear Infection Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Companion Animal Ear Infection Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Companion Animal Ear Infection Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Companion Animal Ear Infection Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Companion Animal Ear Infection Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Companion Animal Ear Infection Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Companion Animal Ear Infection Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Companion Animal Ear Infection Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Companion Animal Ear Infection Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Companion Animal Ear Infection Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Companion Animal Ear Infection Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Companion Animal Ear Infection Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Companion Animal Ear Infection Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Companion Animal Ear Infection Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Companion Animal Ear Infection Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Companion Animal Ear Infection Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Companion Animal Ear Infection Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Companion Animal Ear Infection Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Companion Animal Ear Infection Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Companion Animal Ear Infection Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Companion Animal Ear Infection Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Companion Animal Ear Infection Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Companion Animal Ear Infection Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Companion Animal Ear Infection Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Companion Animal Ear Infection Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Companion Animal Ear Infection Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Companion Animal Ear Infection Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Companion Animal Ear Infection Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Companion Animal Ear Infection Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Companion Animal Ear Infection Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Companion Animal Ear Infection Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Companion Animal Ear Infection Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Companion Animal Ear Infection Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Companion Animal Ear Infection Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Companion Animal Ear Infection Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Companion Animal Ear Infection Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Companion Animal Ear Infection Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Companion Animal Ear Infection Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Companion Animal Ear Infection Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Companion Animal Ear Infection Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Companion Animal Ear Infection Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Companion Animal Ear Infection Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Companion Animal Ear Infection Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Companion Animal Ear Infection Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Companion Animal Ear Infection Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Companion Animal Ear Infection Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Companion Animal Ear Infection Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Companion Animal Ear Infection Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Companion Animal Ear Infection Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Companion Animal Ear Infection Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Companion Animal Ear Infection Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Companion Animal Ear Infection Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Companion Animal Ear Infection Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Companion Animal Ear Infection Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Companion Animal Ear Infection Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Companion Animal Ear Infection Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Companion Animal Ear Infection Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Calder Vets
  2. 8.1.1 Calder Vets Company Information
  3. 8.1.2 Calder Vets Business Overview
  4. 8.1.3 Calder Vets Companion Animal Ear Infection Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Calder Vets Companion Animal Ear Infection Product Portfolio
  6. 8.1.5 Calder Vets Recent Developments
  7. 8.2 Dechra Pharmaceuticals
  8. 8.2.1 Dechra Pharmaceuticals Company Information
  9. 8.2.2 Dechra Pharmaceuticals Business Overview
  10. 8.2.3 Dechra Pharmaceuticals Companion Animal Ear Infection Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Dechra Pharmaceuticals Companion Animal Ear Infection Product Portfolio
  12. 8.2.5 Dechra Pharmaceuticals Recent Developments
  13. 8.3 Elanco Animal Health Incorporated
  14. 8.3.1 Elanco Animal Health Incorporated Company Information
  15. 8.3.2 Elanco Animal Health Incorporated Business Overview
  16. 8.3.3 Elanco Animal Health Incorporated Companion Animal Ear Infection Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Elanco Animal Health Incorporated Companion Animal Ear Infection Product Portfolio
  18. 8.3.5 Elanco Animal Health Incorporated Recent Developments
  19. 8.4 Penn Veterinary Supply
  20. 8.4.1 Penn Veterinary Supply Company Information
  21. 8.4.2 Penn Veterinary Supply Business Overview
  22. 8.4.3 Penn Veterinary Supply Companion Animal Ear Infection Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Penn Veterinary Supply Companion Animal Ear Infection Product Portfolio
  24. 8.4.5 Penn Veterinary Supply Recent Developments
  25. 8.5 Piedmont Animal Health
  26. 8.5.1 Piedmont Animal Health Company Information
  27. 8.5.2 Piedmont Animal Health Business Overview
  28. 8.5.3 Piedmont Animal Health Companion Animal Ear Infection Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Piedmont Animal Health Companion Animal Ear Infection Product Portfolio
  30. 8.5.5 Piedmont Animal Health Recent Developments
  31. 8.6 VCA
  32. 8.6.1 VCA Company Information
  33. 8.6.2 VCA Business Overview
  34. 8.6.3 VCA Companion Animal Ear Infection Revenue and Gross Margin (2021-2026)
  35. 8.6.4 VCA Companion Animal Ear Infection Product Portfolio
  36. 8.6.5 VCA Recent Developments
  37. 8.7 Vedco
  38. 8.7.1 Vedco Company Information
  39. 8.7.2 Vedco Business Overview
  40. 8.7.3 Vedco Companion Animal Ear Infection Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Vedco Companion Animal Ear Infection Product Portfolio
  42. 8.7.5 Vedco Recent Developments
  43. 8.8 Vetoquinol S.A.
  44. 8.8.1 Vetoquinol S.A. Company Information
  45. 8.8.2 Vetoquinol S.A. Business Overview
  46. 8.8.3 Vetoquinol S.A. Companion Animal Ear Infection Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Vetoquinol S.A. Companion Animal Ear Infection Product Portfolio
  48. 8.8.5 Vetoquinol S.A. Recent Developments
  49. 8.9 Virbac S.A.
  50. 8.9.1 Virbac S.A. Company Information
  51. 8.9.2 Virbac S.A. Business Overview
  52. 8.9.3 Virbac S.A. Companion Animal Ear Infection Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Virbac S.A. Companion Animal Ear Infection Product Portfolio
  54. 8.9.5 Virbac S.A. Recent Developments
  55. 8.10 Wedgewood Village Pharmacy
  56. 8.10.1 Wedgewood Village Pharmacy Company Information
  57. 8.10.2 Wedgewood Village Pharmacy Business Overview
  58. 8.10.3 Wedgewood Village Pharmacy Companion Animal Ear Infection Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Wedgewood Village Pharmacy Companion Animal Ear Infection Product Portfolio
  60. 8.10.5 Wedgewood Village Pharmacy Recent Developments
  61. 8.11 Merck & Co
  62. 8.11.1 Merck & Co Company Information
  63. 8.11.2 Merck & Co Business Overview
  64. 8.11.3 Merck & Co Companion Animal Ear Infection Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Merck & Co Companion Animal Ear Infection Product Portfolio
  66. 8.11.5 Merck & Co Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst